Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Lupus Clinical Trials in Houston | 113 Studies

Clinical Trials LupusHouston

Lupus Clinical Trials in Houston

Find 113 clinical trials for lupus near Houston, Texas. Connect with research centers in your area.

All Lupus trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 61-80 of 113 trials

CompletedA Study of Belimumab in Subjects With Systemic Lupus ErythematosusThe purpose of this study is to evaluate the efficacy, safety, tolerability, and impact on quality of life of two different doses of belimumab administered in addition to standard…NCT00410384·Birmingham, Alabama and 145 others

PreviousPage 4 of 6Next

Lupus Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

TerminatedA Long-Term Study of the Safety and Tolerability of Repeated Administration of CEP-33457 in Participants With Systemic Lupus ErythematosusThe primary objective of this study is to evaluate the long term safety and tolerability of repeated administration of subcutaneous (SC) CEP-33457 for injection every 4 weeks over…NCT01240694·Birmingham, Alabama and 84 others

RecruitingTesting an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOThis phase Ib trial studies the side effects of nivolumab and to see how well it works alone and in combination with other treatments, such as ipilimumab, cabozantinib, platinum…NCT03816345·Birmingham, Alabama and 51 others

Active not recruitingA 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus ErythematosusIn this study, researchers will learn more about a study drug called litifilimab (BIIB059) in participants with cutaneous lupus erythematosus (CLE).NCT05531565·Anniston, Alabama and 314 others

RecruitingRESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus ErythematosusRESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus ErythematosusNCT06121297·Orange, California and 22 others

Active not recruitingA Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)This is a prospective, open-label, single arm 3-year clinical study to describe the short-term and long-term efficacy and safety of belimumab in participants with autoantibody…NCT06411249·Anniston, Alabama and 103 others

CompletedA Study of KZR-616 in Patients With SLE With and Without Lupus NephritisThis was a Phase 1b/2, multi-center study in which patients received KZR-616, administered as a subcutaneous (SC) injection weekly for 13 weeks (Phase 1b) or 24 weeks (Phase 2).NCT03393013·Los Angeles, California and 35 others

Active not recruitingPhase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus NephritisThe purpose of this study is to evaluate the efficacy and safety of IV antifrolumab in adult patients with Active Proliferative Lupus NephritisNCT05138133·Glendale, Arizona and 163 others

Active not recruitingTwo-period Crossover Study to Demonstrate the Comparability of Pharmacokinetics of Subcutaneous Ianalumab Between 2mL Auto-injector/2mL PFS with1mL Pre-filled Syringe in Adult Participants With Autoimmune DiseaseThe purpose of this study is to demonstrate the comparability of ianalumab exposure following the sub-cutaneous (s.c.) administration of one injection of 300 mg/2 mL auto-injector…NCT06293365·Anniston, Alabama and 36 others

TerminatedAscension® Post- Approval Study; PyroCarbon Metacarpophalangeal Total Joint ProsthesisThis study is a non-randomized, consecutive enrollment, one-year post-approval study of patients who are treated with the Ascension® MCP.NCT02408471·Tucson, Arizona and 8 others

CompletedOpen Label Extension Study of Epratuzumab in Subjects With Systemic Lupus ErythematosusThe primary objective of the study is assess the safety and tolerability of long-term epratuzumab treatment in subjects with Systemic Lupus Erythematosus (SLE)NCT01408576·Birmingham, Alabama and 227 others

CompletedEfficacy and Safety of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus ErythematosusThe purpose of this study is to evaluate the efficacy and safety of an intravenous treatment regimen of two doses of anifrolumab versus placebo in adult subjects with moderately…NCT02446912·Birmingham, Alabama and 144 others

TerminatedA Study of Baricitinib (LY3009104) in Participants With Systemic Lupus ErythematosusThe reason for this study is to see how effective and safe the study drug known as baricitinib is in participants with systemic lupus erythematosus (SLE).NCT03616912·Birmingham, Alabama and 183 others

CompletedEfficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus ErythematosusThe purpose of the study is to assess the efficacy and safety of 4 doses of cenerimod versus placebo in adult subjects with systemic lupus erythematosus (SLE).NCT03742037·Anniston, Alabama and 147 others

CompletedA DOSE-RANGING STUDY TO EVALUATE EFFICACY AND SAFETY OF PF-06700841 IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)Assessment of PF-06700841 in participants with moderate to severe active, generalized Systemic Lupus Erythematosus (SLE) that have inadequate response to standard of care.NCT03845517·Birmingham, Alabama and 163 others

Active not recruitingA Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)The purpose of this study is to evaluate the efficacy and safety of rapcabtagene autoleucel (administered once following lymphodepletion) in patients with active, refractory…NCT06581198·Birmingham, Alabama and 106 others

CompletedA Study of LY3471851 in Adults With Systemic Lupus Erythematosus (SLE)The reason for this study is to see if the study drug LY3471851 (NKTR-358) is safe and effective in adults with systemic lupus erythematosus (SLE).NCT04433585·La Jolla, California and 111 others

CompletedA Continuation Trial for Subjects With Systemic Lupus Erythematosus That Have Completed Protocol LBSL02This is a continuation study to evaluate the long-term safety and efficacy of LymphoStat-B™ in subjects with SLE disease, that completed study LBSL02 and benefitted from treatment.NCT00583362·Birmingham, Alabama and 56 others

CompletedA Study Evaluating the Effects of GLPG3667 Administered as Oral Treatment in Adult Participants With Active Systemic Lupus ErythematosusA study evaluating the efficacy, safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of GLPG3667 administered orally once daily for 48 weeks in approximately…NCT05856448·Tucson, Arizona and 83 others

CompletedA Study to Evaluate the Efficacy and Safety of CEP-33457 in Participants With Systemic Lupus Erythematosus (SLE)The primary objective of this study is to evaluate the efficacy of a 200 micrograms (mcg) dose of CEP-33457 compared with placebo in participants with active systemic lupus…NCT01135459·Birmingham, Alabama and 85 others

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia